The Chairman Rob Thomas in the 2017 annual report stated "In terms of the year ahead, Starpharma is on the cusp of several near term catalysts: commercialisation of its VivaGel® BV products; commencement and progress of clinical trials for multiple DEP® candidates; and more DEP®partnerships.
Since we were on the cusp of more DEP partnerships in Aug 2017 and more than 12 months has passed.
Have I missed information on any DEP partnerships being signed since Aug 2017? Surely he was not talking about Vivagel partnerships.
